Marshall Islands vs Zambia: Prevalence rate of hypertension in men aged 30-79
Marshall Islands
30.8
in 2019
Zambia
30.3
in 2019
Marshall Islands rank
169th
Zambia rank
172nd
Prevalence rate of hypertension in men aged 30-79 over time
- Marshall Islands
- Zambia
How they compare
Marshall Islands currently reports 30.8 against 30.3 in Zambia, a difference of 0.5.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Zambia ahead.
Marshall Islands ranks 169th and Zambia ranks 172nd of 195 countries.
Zambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Marshall Islands | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 28.37 | 34.44 | 6.07 | Zambia |
| 2000s | 28.27 | 35.93 | 7.66 | Zambia |
| 2010s | 30.29 | 32.96 | 2.67 | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence rate of hypertension in men aged 30-79, Marshall Islands or Zambia?
- Marshall Islands, at 30.8 against 30.3 in Zambia as of 2019.
- What is the difference in prevalence rate of hypertension in men aged 30-79 between Marshall Islands and Zambia?
- 0.5, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and Zambia?
- 30 years are reported by both, from 1990 to 2019.
- How do Marshall Islands and Zambia rank globally for prevalence rate of hypertension in men aged 30-79?
- Marshall Islands ranks 169th and Zambia ranks 172nd of 195 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Prevalence rate of hypertension in men aged 30-79. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated share of male population with hypertension, based on population representative surveys and statistical modeling. Hypertension is a risk factor for chronic complications, including cardiovascular disease, and premature death.